DURECT Corporation

1.72-0.0700-3.91%Vol 126.44K1Y Perf -8.56%
Apr 16th, 2021 09:45 DELAYED
BID1.71 ASK1.72
Open1.78 Previous Close1.79
Pre-Market- After-Market-
 - -%  - -
Target Price
6.67 
Analyst Rating
Strong Buy 1.50
Potential %
272.63 
Finscreener Ranking
★★★★+     57.88
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★★★+     60.02
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★★★     62.48
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Market Cap390.79M 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
13.89 
Earnings Date
10th May 2021

Today's Price Range

1.701.78

52W Range

1.522.96

5 Year PE Ratio Range

-11.50-8.70

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-3.24%
1 Month
-24.47%
3 Months
-11.82%
6 Months
-3.76%
1 Year
-8.56%
3 Years
-28.69%
5 Years
27.86%
10 Years
-44.92%

TickerPriceChg.Chg.%
DRRX1.72-0.0700-3.91
AAPL133.92-0.5800-0.43
GOOG2 292.28-4.3800-0.19
MSFT258.72-0.7800-0.30
XOM57.130.15000.26
WFC42.760.52001.23
JNJ161.350.96000.60
FB305.65-2.1700-0.70
GE13.550.00000.00
JPM153.351.18000.78
ValuationValueIndustryS&P 500US Markets
-188.00
10.65
14.46
288.60
-16.50
-0.19
12.58
0.18
412.22M
Forward PE-11.56
PEG-12.53
Financial StrengthValueIndustryS&P 500US Markets
3.90
5.90
0.37
0.64
-5.40
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
95.30
-40.20
-39.20
-104.60
38.62
RevenueValueIndustryS&P 500US Markets
27.34M
0.12
-8.97
11.62
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.03-0.04-33.33
Q03 2020-0.04-0.05-25.00
Q02 20200.040.0775.00
Q01 2020-0.04-0.05-25.00
Q04 2019-0.02-0.020.00
Q03 2019-0.02-0.0150.00
Q02 2019-0.05-0.0420.00
Q01 2019-0.05-0.0420.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.05-66.67Negative
6/2021 QR-0.050.00-
12/2021 FY-0.1814.29Positive
12/2022 FY-0.165.88Positive
Next Report Date10th May 2021
Estimated EPS Next Report-0.05
Estimates Count4
EPS Growth Next 5 Years %15.00
Volume Overview
Volume126.44K
Shares Outstanding227.20M
Trades Count377
Dollar Volume5.83M
Avg. Volume2.07M
Avg. Weekly Volume744.37K
Avg. Monthly Volume1.07M
Avg. Quarterly Volume2.30M

DURECT Corporation (NASDAQ: DRRX) stock closed at 1.79 per share at the end of the most recent trading day (a 1.7% change compared to the prior day closing price) with a volume of 1.27M shares and market capitalization of 390.79M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 95 people. DURECT Corporation CEO is James E. Brown.

The one-year performance of DURECT Corporation stock is -8.56%, while year-to-date (YTD) performance is -13.53%. DRRX stock has a five-year performance of 27.86%. Its 52-week range is between 1.52 and 2.96, which gives DRRX stock a 52-week price range ratio of 13.89%

DURECT Corporation currently has a PE ratio of -188.00, a price-to-book (PB) ratio of 10.65, a price-to-sale (PS) ratio of 14.46, a price to cashflow ratio of 288.60, a PEG ratio of 2.32, a ROA of -0.69%, a ROC of -13.89% and a ROE of -1.79%. The company’s profit margin is 38.62%, its EBITDA margin is -39.20%, and its revenue ttm is $27.34 Million , which makes it $0.12 revenue per share.

Of the last four earnings reports from DURECT Corporation, there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.05 for the next earnings report. DURECT Corporation’s next earnings report date is 10th May 2021.

The consensus rating of Wall Street analysts for DURECT Corporation is Strong Buy (1.5), with a target price of $6.67, which is +272.63% compared to the current price. The earnings rating for DURECT Corporation stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

DURECT Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

DURECT Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 16.87, ATR14 : 0.18, CCI20 : -101.03, Chaikin Money Flow : -0.22, MACD : -0.15, Money Flow Index : 25.82, ROC : -3.76, RSI : 42.56, STOCH (14,3) : 32.99, STOCH RSI : 0.78, UO : 49.61, Williams %R : -67.01), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of DURECT Corporation in the last 12-months were: Judy R. Joice (Option Excercise at a value of $45 100), Judy R. Joice (Sold 57 820 shares of value $141 763 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.50

DURECT Corporation

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, Remoxy, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.

CEO: James E. Brown

Telephone: +1 408 777-1417

Address: 10260 Bubb Road, Cupertino 95014, CA, US

Number of employees: 95

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

47%53%

Bearish Bullish

50%50%

Bearish Bullish

53%47%

News

Stocktwits